Application 075498

Type
ANDA
Sponsor
HIKMA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TERAZOSIN HYDROCHLORIDETERAZOSIN HYDROCHLORIDECAPSULE;ORALEQ 1MG BASENoNo
002TERAZOSIN HYDROCHLORIDETERAZOSIN HYDROCHLORIDECAPSULE;ORALEQ 2MG BASENoNo
003TERAZOSIN HYDROCHLORIDETERAZOSIN HYDROCHLORIDECAPSULE;ORALEQ 5MG BASENoNo
004TERAZOSIN HYDROCHLORIDETERAZOSIN HYDROCHLORIDECAPSULE;ORALEQ 10MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
10544-289TerazosinTerazosinBlenheim Pharmacal, Inc.ANDACurrent
33261-211TerazosinTerazosinAidarex Pharmaceuticals LLCANDACurrent
33261-212TerazosinTerazosinAidarex Pharmaceuticals LLCANDACurrent
33261-870TerazosinTerazosinAidarex Pharmaceuticals LLCANDACurrent
53808-0306Terazosin HydrochlorideTerazosin HydrochlorideState of Florida DOH Central PharmacyANDACurrent
53808-0308Terazosin HydrochlorideTerazosin HydrochlorideState of Florida DOH Central PharmacyANDACurrent
53808-0930Terazosin HydrochlorideTerazosin HydrochlorideState of Florida DOH Central PharmacyANDACurrent
68788-9673TerazosinTerazosinPreferred PharmaceuticalsANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
8695ORIG2001-04-12